US › Healthcare

Sunshine Biopharma Inc (SBFM)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.22-3.48%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$9.3M

Revenue YoY

-1.6%

Net profit

$-1.6M

EPS

$-1.15

EPS estimate

$-1.20

Net margin

-16.9%

EPS came in at -1.15 against a street estimate of -1.20 — a beat of 4.2%.

Key statistics

Market cap

$3.3M

Forward P/E

0.0

P/B

0.13

Book value

$11.52

EPS (TTM)

$-9.45

52-week high

$23.20

52-week low

$0.19

50-day MA

$0.91

200-day MA

$6.09

Beta

1.35

Analyst view

Analysts rate Sunshine Biopharma Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $56.00.

Shareholding

Insiders

6.43%

Institutions

7.79%

Largest institutional holders

Fund	Stake
Jane Street Group LLC	3.05%
Morgan Stanley - Brokerage Accounts	0.08%
SBI Securities Co Ltd	0.03%
NATIONAL BANK OF CANADA /FI/	0.00%
Advisor Group Holdings, Inc.	0.00%
TD Waterhouse Canada Inc	0.00%
Caitong International Asset Management Co., Limited.	0.00%
Strive Financial Group ,LLC	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Sunshine Biopharma Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.